The Worldwide Biosimilars Industry is Expected to Reach $44.7 Billion by 2026

NEXT STORY
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
PREV STORY
Statera Biopharma, Inc. to Report Third Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Worldwide Geographic Information System Industry to 2026 – Asia-Pacific to Register Highest Market Growth

author_avatar
NASDAQ Market News

New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A

author_avatar
NASDAQ Market News

Arcutis Enrolls Last Patient in Phase 2b Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp Psoriasis

author_avatar
NASDAQ Market News